#1 Clinical Trials Search in Europe

Fluorouracil

Fluorouracil, also known as 5-FU, is a topical medication being studied in clinical trials for the treatment of actinic keratoses (AKs) and photoaging. These trials aim to evaluate the efficacy, safety, and optimal use of fluorouracil compared to other treatments or in combination with other therapies for managing sun-damaged skin.

Table of Contents

What is Fluorouracil?

Fluorouracil, also known as 5-Fluorouracil or 5-FU, is a chemotherapy drug widely used in the treatment of various types of cancer[1]. It belongs to a class of medications called antimetabolites, which work by interfering with the growth of cancer cells[2]. Fluorouracil has been a cornerstone in cancer treatment for many years, particularly in colorectal cancer therapy.

What Conditions Does Fluorouracil Treat?

Fluorouracil is used to treat several types of cancer, including:

  • Colorectal Cancer: It is commonly used in both early-stage and advanced colorectal cancer[3].
  • Metastatic Colorectal Cancer: Fluorouracil is a key component in treating colorectal cancer that has spread to other parts of the body, particularly the liver[4].
  • Breast Cancer: It is used in combination with other drugs for breast cancer treatment[5].
  • Head and Neck Cancer: Fluorouracil is part of treatment regimens for squamous cell carcinoma of the head and neck[2].
  • Actinic Keratoses: A topical form of fluorouracil is used to treat this precancerous skin condition[6].

How Does Fluorouracil Work?

Fluorouracil works by interfering with the growth of cancer cells. It does this by mimicking a substance called uracil, which is a building block of DNA. When cancer cells try to use fluorouracil instead of uracil, it disrupts their ability to make new DNA and RNA, which are essential for cell growth and division. This ultimately leads to the death of cancer cells[3].

How is Fluorouracil Administered?

Fluorouracil can be administered in several ways, depending on the type of cancer being treated and the specific treatment plan:

  • Intravenous (IV) Infusion: This is the most common method for treating internal cancers. Fluorouracil is often given as a continuous infusion over 46-48 hours[4].
  • Bolus Injection: Sometimes, a quick injection of a higher dose is given[4].
  • Topical Application: For skin conditions like actinic keratoses, fluorouracil is applied directly to the skin as a cream[6].
  • Hepatic Arterial Infusion (HAI): In some cases of liver metastases, fluorouracil may be administered directly to the liver through a special pump[4].

Fluorouracil in Combination Therapies

Fluorouracil is often used in combination with other drugs to enhance its effectiveness. Some common combination therapies include:

  • FOLFOX: A combination of Fluorouracil, Leucovorin, and Oxaliplatin[1].
  • FOLFIRI: A combination of Fluorouracil, Leucovorin, and Irinotecan[4].
  • FOLFIRINOX: A combination of Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin[3].
  • FEC: A combination of Fluorouracil, Epirubicin, and Cyclophosphamide, used in breast cancer treatment[5].

Possible Side Effects

Like all chemotherapy drugs, fluorouracil can cause side effects. These can vary depending on how the drug is administered and may include:

  • Nausea and vomiting
  • Diarrhea
  • Mouth sores
  • Decreased appetite
  • Fatigue
  • Increased risk of infection due to lowered white blood cell count
  • Skin reactions (especially with topical use)[6]

Your healthcare team will monitor you closely for these side effects and can provide treatments to help manage them.

Ongoing Research and Clinical Trials

Researchers continue to study fluorouracil to find ways to improve its effectiveness and reduce side effects. Some areas of ongoing research include:

  • Dose Adjustment: Studies are looking at ways to adjust the dose of fluorouracil based on its concentration in the blood, which may improve effectiveness and reduce side effects[3].
  • Combination Therapies: Researchers are exploring new combinations of fluorouracil with other drugs to enhance its effectiveness[7].
  • Targeted Delivery: Methods like hepatic arterial infusion are being studied to deliver fluorouracil more directly to cancer cells[4].
  • Topical Applications: Research is ongoing to improve the use of topical fluorouracil for skin conditions, including ways to reduce local skin reactions[6].

These ongoing studies aim to improve the effectiveness of fluorouracil while minimizing its side effects, potentially leading to better outcomes for patients in the future.

Aspect Details
Primary Use Treatment of actinic keratoses and photoaging
Application Method Topical cream applied to affected skin areas
Treatment Duration Typically 2-4 weeks
Common Side Effects Skin irritation, redness, scaling, crusting, erosions
Efficacy Measures AK lesion count reduction, skin appearance improvement, histological changes
Combination Therapies Studied with photodynamic therapy, emollients, cryotherapy
Patient Populations Adults with sun-damaged skin, including elderly patients
Follow-up Periods Ranging from 1 month to 12 months post-treatment
Secondary Outcomes Patient satisfaction, quality of life, cosmetic outcomes

FAQ

  • What is fluorouracil used for in these clinical trials? Fluorouracil is being studied for treating actinic keratoses (pre-cancerous skin lesions) and photoaging (sun damage) on areas like the face, scalp, and forearms.
  • How is fluorouracil typically applied in these studies? In most trials, fluorouracil cream is applied topically to the affected skin areas once or twice daily for a period of 2-4 weeks.
  • What are some of the potential side effects of fluorouracil treatment? Common side effects can include skin irritation, redness, scaling, crusting, and erosions in the treated areas. The severity of these reactions is often monitored in the trials.
  • How do researchers measure the effectiveness of fluorouracil in these trials? Effectiveness is typically measured by counting the number of actinic keratoses before and after treatment, assessing overall skin appearance, and sometimes taking skin biopsies to examine changes at the cellular level.
  • Are there any combination therapies being studied with fluorouracil? Yes, some trials are investigating the use of fluorouracil in combination with other treatments like photodynamic therapy (PDT) or emollient creams to potentially improve efficacy or reduce side effects.

Ongoing Clinical Trials on Fluorouracil

  • Volrustomig in Patients with Unresectable Pleural Mesothelioma and Esophageal Squamous Cell Carcinoma

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy

  • Testing a Drug Combination with Fluorouracil, Irinotecan, Oxaliplatin, and Folinic Acid Plus Radiation Therapy for Patients with Advanced Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated drugs:
    The Netherlands

  • A Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium Czechia France Germany Hungary Italy +2

  • Testing GSK5764227 combined with standard cancer treatments in patients with advanced solid tumors to evaluate safety and effectiveness

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study of chemotherapy drug combination with or without heated chemotherapy in the abdomen for patients with advanced colon cancer

    Recruiting

    3 1 1 1
    Investigated drugs:
    Spain

  • Study of FOLFOX or FOLFIRI chemotherapy with fruquintinib or bevacizumab as second-line treatment for patients with metastatic colorectal cancer

    Recruiting

    2 1 1 1
    Investigated drugs:
    France

  • A Study Comparing PF-08634404 and a Drug Combination with Chemotherapy in Adults with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium Denmark France Germany Italy The Netherlands +2

  • A study of pumitamig and a drug combination versus nivolumab and a drug combination for patients with untreated advanced or metastatic stomach or esophageal cancer

    Recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Romania Spain

  • A study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer

    Recruiting

    4 1 1 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Italy +5

  • Study of Sotorasib, Panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark Estonia +12

Glossary

  • Actinic Keratosis (AK): A rough, scaly patch on the skin caused by years of sun exposure. It's considered a pre-cancerous lesion that can potentially develop into skin cancer.
  • Photoaging: Premature aging of the skin caused by repeated exposure to ultraviolet radiation, primarily from the sun or tanning beds.
  • 5-Fluorouracil (5-FU): A type of topical chemotherapy medication used to treat certain skin conditions, including actinic keratoses and some skin cancers.
  • Photodynamic Therapy (PDT): A treatment that combines light-sensitive drugs with light exposure to destroy abnormal cells. It's sometimes used in combination with other treatments for skin conditions.
  • Erythema: Redness of the skin caused by increased blood flow. It's a common side effect of topical treatments like fluorouracil.
  • Cryotherapy: A treatment that uses extreme cold to freeze and destroy abnormal tissue, such as actinic keratoses.
  • Emollient: A moisturizing treatment used to soothe and hydrate the skin, sometimes used in combination with other skin treatments.
  • Biopsy: A medical procedure where a small sample of tissue is taken from the body to be examined under a microscope.
  • Keratinocyte Carcinoma: A type of skin cancer that develops from keratinocytes, the most common type of skin cell.
  • Immunohistochemistry: A laboratory method used to detect specific proteins in tissues, often used to study the effects of treatments at a cellular level.

References

  1. https://clinicaltrials.gov/study/NCT00689624
  2. https://clinicaltrials.gov/study/NCT00995293
  3. https://clinicaltrials.gov/study/NCT06501989
  4. https://clinicaltrials.gov/study/NCT03069950
  5. https://clinicaltrials.gov/study/NCT02225652
  6. https://clinicaltrials.gov/study/NCT04875026
  7. https://clinicaltrials.gov/study/NCT06332079